GW Pharma Q4 Revenue Increases 36% to $148 Million

GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2020 Financial Results and Operational Progress Total revenue of $148.2 million for the fourth quarter and $527.2 million for the full year Total Epidiolex® net product sales of $144.1 million for the fourth quarter and $510.5 million for the full year Previously announced agreement to be acquired by […]